Enhabit, Inc. (NYSE:EHAB) Shares Acquired by West Tower Group LLC

West Tower Group LLC grew its stake in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 108.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 285,142 shares of the company's stock after acquiring an additional 148,566 shares during the period. Enhabit comprises approximately 4.8% of West Tower Group LLC's investment portfolio, making the stock its 3rd biggest holding. West Tower Group LLC owned approximately 0.57% of Enhabit worth $2,253,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of EHAB. SummerHaven Investment Management LLC increased its holdings in shares of Enhabit by 2.8% during the second quarter. SummerHaven Investment Management LLC now owns 61,508 shares of the company's stock valued at $549,000 after acquiring an additional 1,660 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Enhabit by 5.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company's stock worth $443,000 after acquiring an additional 2,078 shares during the last quarter. Quarry LP lifted its position in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after acquiring an additional 2,621 shares during the period. Gladius Capital Management LP increased its holdings in shares of Enhabit by 78.2% in the third quarter. Gladius Capital Management LP now owns 6,259 shares of the company's stock valued at $49,000 after purchasing an additional 2,747 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in shares of Enhabit by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company's stock worth $3,573,000 after purchasing an additional 5,936 shares during the last quarter.

Enhabit Stock Performance

Shares of EHAB traded up $0.01 during midday trading on Tuesday, reaching $7.63. 137,446 shares of the stock were exchanged, compared to its average volume of 580,402. The company has a market capitalization of $383.64 million, a price-to-earnings ratio of -3.29 and a beta of 1.84. The business's 50-day moving average price is $7.50 and its 200 day moving average price is $8.37. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same quarter in the previous year, the business earned $0.03 EPS. On average, sell-side analysts expect that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Leerink Partners reaffirmed a "market perform" rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. According to data from MarketBeat.com, Enhabit presently has an average rating of "Hold" and a consensus price target of $9.25.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.